Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 08 Jan 2025

Angiomatoid fibrous histiocytoma with EWSR1-CREB1 gene fusion occurs in lungs and ribs with systemic multiple metastases: a case report and review of the literature

in Thoracic Oncology

Dongmei Feng
Ying Li
Zhengjin Li
Yun Pan
Yixuan Gao
Jinyan Cha
Chunmei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1420597

2,407 views
4 citations

Original Research

Published on 07 Jan 2025

Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study

in Thoracic Oncology

Zhou Meng-Xi
Fan Wen-Jie
Zhang Ning
Zhu Li-Yang
Wang Hong-Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1515382

2,821 views
1 citation

Case Report

Published on 07 Jan 2025

Pleural Rosai-Dorfman disease complicated with renal clear cell carcinoma: a case report and literature review

in Thoracic Oncology

Sudan Tang
Xinju Yang
Shunan Wang
Qin Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1476243

1,710 views

Original Research

Published on 07 Jan 2025

A novel interplay between bacteria and metabolites in different early-stage lung cancer: an integrated microbiome and metabolome analysis

in Thoracic Oncology

Xiaoqian Zhai
Dongqi Lin
Yi Shen
Ni Zhai
Fan Yu
Jiabi Zhang
Yiyun Lin
Yuqing Wang
Qinghua Zhou
Xi Zheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1492571

2,958 views
3 citations

Original Research

Published on 07 Jan 2025

Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets

in Thoracic Oncology

Hao-Shuai Yang
Jin Zhang
Hong-Xiang Feng
Fei Qi
Fan-Jia Kong
Wei-Jie Zhu
Chao-Yang Liang
Zhen-Rong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1498524

2,746 views
3 citations

Original Research

Published on 03 Jan 2025

The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035

in Thoracic Oncology

Yifan Wang
Jingwen Zhu
Shaoqiang Wang
Jihong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1511530

4,935 views
3 citations

Case Report

Published on 24 Dec 2024

Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report

in Thoracic Oncology

Márton Csaba
Zsolt Megyesfalvi
László Báthory-Fülöp
Tamás Pintér
László Agócs
Balázs Döme
Ferenc Rényi-Vámos
Áron Kristóf Ghimessy

Frontiers in Oncology

doi 10.3389/fonc.2024.1462865

2,073 views
1 citation

Review

Published on 23 Dec 2024

Artificial intelligence in lung cancer: current applications, future perspectives, and challenges

in Thoracic Oncology

Dongdong Huang
Zifang Li
Tao Jiang
Chaojuan Yang
Ning Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1486310

13,893 views
33 citations

Case Report

Published on 23 Dec 2024

Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review

in Thoracic Oncology

Minghong Xie
Yunlong Zhao
Xiaohua Hou
Ning Li
Sha Niu
Xinju Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1476205

1,912 views
1 citation

Systematic Review

Published on 20 Dec 2024

Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis

in Thoracic Oncology

Wang Yilun
Zhang Yaojing
Shi Hongcan

Frontiers in Oncology

doi 10.3389/fonc.2024.1453021

2,680 views
1 citation

Review

Published on 19 Dec 2024

Biomarkers for immunotherapy resistance in non-small cell lung cancer

in Thoracic Oncology

Catriona Rother
Tom John
Annie Wong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489977

7,687 views
18 citations

Original Research

Published on 17 Dec 2024

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

in Thoracic Oncology

Aida Piedra
Sergio Martínez-Recio
Ainhoa Hernández
Teresa Morán
Edurne Arriola
Jordi Recuero-Borau
Manuel Cobo
Patricia Cordeiro
Joaquín Mosquera
Manuel Fernández

Frontiers in Oncology

doi 10.3389/fonc.2024.1510278

3,630 views
2 citations

Case Report

Published on 13 Dec 2024

Huge extramedullary hematopoiesis mass in the posterior mediastinum: a case report

in Thoracic Oncology

Zhao Junjun
Dong Lingjun
Ma Zhifeng
Zhang Chu
Wang Haiyong

Frontiers in Oncology

doi 10.3389/fonc.2024.1489785

1,813 views

Original Research

Published on 13 Dec 2024

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

in Thoracic Oncology

Lele Huang
Weifang Kong
Yongjun Luo
Hongjun Xie
Jiangyan Liu
Xin Zhang
Guojin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1458374

2,001 views
3 citations

Original Research

Published on 12 Dec 2024

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

in Thoracic Oncology

Valérie Labrie
Judith Lefebvre
Catherine Labbé
Kevin Jao
Mandy Malick
Serge Simard
Nicole Bouchard

Frontiers in Oncology

doi 10.3389/fonc.2024.1506172

2,101 views
2 citations

Original Research

Published on 12 Dec 2024

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

in Thoracic Oncology

Meiling Lan
Tianyun Wang
Diexiao Luo
Yan Chen
Wei Liang
Rui Kong
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1472545

1,737 views

Case Report

Published on 11 Dec 2024

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report

in Thoracic Oncology

Jian Wang
Bingyue Liu
Qinhong Zheng
Ruoshui Xiao
Jianxin Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1507658

2,078 views
5 citations

Case Report

Published on 11 Dec 2024

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

in Thoracic Oncology

Can-hui Jian
Shuai Luo
Jin-jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1509132

1,955 views
1 citation

Case Report

Published on 11 Dec 2024

Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features

in Thoracic Oncology

Ting Duan
Mingxin Xu
Haibo Zhang
Shengchang Wu
Haochu Wang
Zhenying Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1453895

2,858 views
6 citations

Review

Published on 09 Dec 2024

Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies

in Thoracic Oncology

Li Zhang
Feiyue Zhang
Gaofeng Li
Xudong Xiang
Haifeng Liang
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1422623

2,565 views

Original Research

Published on 06 Dec 2024

Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

in Thoracic Oncology

Jiaying Deng
Lei Zhang
Zezhou Wang
Bin Li
Jiaqing Xiang
Longfei Ma
Hongcheng Zhu
Yuan Li
Kuaile Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1442212

2,470 views
4 citations

Perspective

Published on 05 Dec 2024

Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC

in Thoracic Oncology

Michelle Shiller
Melissa Johnson
Robert Auber
Sandip Pravin Patel

Frontiers in Oncology

doi 10.3389/fonc.2024.1459737

5,256 views
3 citations

Original Research

Published on 04 Dec 2024

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy

in Thoracic Oncology

Yi Ge
Xiaoyu Liu
Yishi Xu
Yanwei Su
Yixin Li
Liping Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1485849

2,545 views
5 citations

Original Research

Published on 04 Dec 2024

A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients

in Thoracic Oncology

Lifang Zhang
Ying Liu
Di Han
Yan Wang
Fanqi Geng
Wei Ding
Xuejuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1463805

1,976 views
1 citation

1,970 articles

articles

Angiomatoid fibrous histiocytoma with EWSR1-CREB1 gene fusion occurs in lungs and ribs with systemic multiple metastases: a case report and review of the literature

Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study

Pleural Rosai-Dorfman disease complicated with renal clear cell carcinoma: a case report and literature review

A novel interplay between bacteria and metabolites in different early-stage lung cancer: an integrated microbiome and metabolome analysis

Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets

The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035

Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report

Artificial intelligence in lung cancer: current applications, future perspectives, and challenges

Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review

Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis

Biomarkers for immunotherapy resistance in non-small cell lung cancer

First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study

Huge extramedullary hematopoiesis mass in the posterior mediastinum: a case report

Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals

Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report

Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report

Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features

Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies

Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy

A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients